Artículos de revistas
Central muscarinic receptors signal pilocarpine-induced salivation
Fecha
2003-12-01Registro en:
Journal of Dental Research. Thousand Oaks: Sage Publications Inc., v. 82, n. 12, p. 993-997, 2003.
0022-0345
10.1177/154405910308201211
WOS:000186818500011
6551236936295697
1023597870118105
Autor
Universidade Estadual Paulista (Unesp)
Institución
Resumen
Although cholinergic agonists such as pilocarpine injected peripherally can act directly on salivary glands to induce salivation, it is possible that their action in the brain may contribute to salivation. To investigate if the action in the brain is important to salivation, we injected pilocarpine intraperitoneally after blockade of central cholinergic receptors with atropine methyl bromide (atropine-mb). In male Holtzman rats with stainless steel cannulas implanted into the lateral ventricle and anesthetized with ketamine, atropine-mb (8 and 16 nmol) intracerebroventricularly reduced the salivation induced by pilocarpine (4 mumol/kg) intraperitoneally (133 +/- 42 and 108 +/- 22 mg/7 min, respectively, vs. saline, 463 +/- 26 mg/7 min), but did not modify peripheral cardiovascular responses to intravenous acetylcholine. Similar doses of atropine-mb intraperitoneally also reduced pilocarpine-induced salivation. Therefore, systemically injected pilocarpine also enters the brain and acts on central muscarinic receptors, activating autonomic efferent fibers to induce salivation.